|
| |
| | | 66215 | | 19.06.2017 | | Eli Lilly (Suisse) SA | | | | | | | | | | | | | 07.15. | | | | 07.15. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Olumiant 2 mg | comprimés pelliculés | Coated tablets (Baricitinibum 2 mg) | L04AA37 | CI | | 02 | Olumiant 4 mg | comprimés pelliculés | Coated tablets (Baricitinibum 4 mg) | L04AA37 | CI |
|
|
|